Cantitate/Preț
Produs

Cerebral Amyloid Angiopathy in Alzheimer’s Disease and Related Disorders

Editat de M.M. Verbeek, R.M. de Waal, Harry V. Vinters
en Limba Engleză Paperback – dec 2010
Cerebral amyloid angiopathy (CAA) is a distinctive abnormality of small cerebral blood vessels, one that has intrigued neuroscientists for decades. The time seems right for a book which examines the phenomenon of CAA using a multifaceted approach: What does it produce clinically? How might CAA be imaged? What are the crucial biochemical/cellular events within cerebral vessel walls that lead to CAA? How can in vitro or transgenic experimental systems be used to understand the etiology of, or even potential treatments for, CAA? The editors have assembled key figures in the field of CAA research to examine these (and other) questions in a series of focused chapters that address specific issues of importance in understanding CAA and its clinical manifestations. Comprehending the biology and pathogenesis of this fascinating vascular lesion may even provide clues to less common forms of cerebral microvascular disease that have been recognized for decades (hypertensive microangiopathy) or more recently (CADASIL).
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 109884 lei  6-8 săpt.
  SPRINGER NETHERLANDS – dec 2010 109884 lei  6-8 săpt.
Hardback (1) 110595 lei  6-8 săpt.
  SPRINGER NETHERLANDS – 31 iul 2000 110595 lei  6-8 săpt.

Preț: 109884 lei

Preț vechi: 115667 lei
-5% Nou

Puncte Express: 1648

Preț estimativ în valută:
21029 21927$ 17477£

Carte tipărită la comandă

Livrare economică 20 martie-03 aprilie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9789048154807
ISBN-10: 9048154804
Pagini: 380
Ilustrații: XX, 358 p.
Dimensiuni: 210 x 279 x 20 mm
Greutate: 0.53 kg
Ediția:Softcover reprint of hardcover 1st ed. 2000
Editura: SPRINGER NETHERLANDS
Colecția Springer
Locul publicării:Dordrecht, Netherlands

Public țintă

Research

Cuprins

Section I: Clinical Aspects of CAA and CAA-Related Hemorrhage.- 1 Clinical aspects and diagnostic criteria of sporadic CAA-related hemorrhage.- 2 Diagnosis of CAA during life. Neuroimaging of CAA.- 3 Vascular risk factors for Alzheimer’s disease. An epidemiologic perspective.- 4 Cerebral microvascular and macrovascular disease in the aging brain; similarities and differences.- Section II: Genetics of CAA.- 5 ApoE genotype in relation to sporadic and Alzheimer-related CAA.- 6 Clinical and genetic aspects of hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D).- 7 Genetics and neuropathology of hereditary cystatin C amyloid angiopathy (HCCAA).- Section III: Cellular and Molecular Pathology of CAA.- 8 Neuropathologic features and grading of Alzheimer-related and sporadic CAA.- 9 Chemical analysis of amyloid ? protein in CAA.- 10 Immunohistochemical analysis of amyloid ? protein isoforms in CAA.- 11 Blood Brain Barrier dysfunction and cerebrovascular degeneration in Alzheimer’s disease.- 12 A?-associated proteins in cerebral amyloid angiopathy.- 13 Neuropathology of hereditary cerebral hemorrhage with amyloidosis-Dutch type.- 14 Neuropathology and genetics of prion protein and British cerebral amyloid angiopathies.- Section IV: In Vitro and Animal Models of CAA.- 15 Amyloid ? protein internalization and production by canine smooth muscle cells.- 16 Degeneration of human cerebrovascular smooth muscle cells and pericytes caused by amyloid ? protein.- 17 Vasoactivity of amyloid ? peptides.- 18 CAA in transgenic mouse models of Alzheimer’s disease. What can we learn from APP transgenic mouse models?.- 19 Cerebral amyloid angiopathy in aged dogs and nonhuman primates.- 20 Vascular transport of Alzheimer’s amyloid ? peptides and apolipoproteins.

Recenzii

`Meantime, this book offers good value for money for those clinicians and scientists interested in the current state of play.'
Brain, 124 (2001)